Literature DB >> 18684932

Binding of C/EBPbeta to the C-reactive protein (CRP) promoter in Hep3B cells is associated with transcription of CRP mRNA.

Duprane Pedaci Young1, Irving Kushner, David Samols.   

Abstract

Expression of the acute phase protein C-reactive protein (CRP) is tightly regulated in hepatocytes. Although very little CRP mRNA is transcribed normally, inflammatory stimuli are followed by a dramatic increase in mRNA synthesis and accumulation. IL-6 and IL-1beta are believed to be the major cytokines responsible for induction of CRP and other acute phase proteins. Our previous studies, using transient transfection and EMSA experiments, implicated involvement of the transcription factors C/EBPbeta, STAT3, Rel p50, and c-Rel in CRP induction. In the current study we used chromatin immunoprecipitation assays to determine the kinetics of transcription factor occupancy of these transcription factors on the endogenous CRP promoter. All of these transcription factors were found bound to the endogenous CRP promoter in the absence of cytokines, but cytokine treatment markedly increased binding of only C/EBPbeta. In addition, c-Rel and TATA box-binding protein (TBP) appeared to occupy the promoter in parallel in the presence of cytokines. In the absence of cytokines, CRP mRNA accumulation was not measurable but began to increase by 3 h after exposure of cells to IL-1beta plus IL-6, peaking at 12 h with secondary peaks at 18 and 24 h. The secondary peaks in mRNA expression paralleled the pattern of binding of c-Rel and TBP to the CRP promoter. We conclude that the CRP promoter has a low level of transcription factor occupancy in the absence of cytokines and induction occurs with binding of C/EBP, and that c-Rel and TBP are important for modulating CRP expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684932     DOI: 10.4049/jimmunol.181.4.2420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Regulation of leukocyte function by adenosine receptors.

Authors:  Joel Linden
Journal:  Adv Pharmacol       Date:  2011

2.  Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.

Authors:  Tomofumi Miura; Yoshihisa Matsumoto; Takashi Hama; Koji Amano; Yo Tei; Ayako Kikuchi; Akihiko Suga; Takayuki Hisanaga; Tatsuhiko Ishihara; Mutsumi Abe; Keisuke Kaneishi; Shohei Kawagoe; Toshiyuki Kuriyama; Takashi Maeda; Ichiro Mori; Nobuhisa Nakajima; Tomohiro Nishi; Hiroki Sakurai; Tatsuya Morita; Hiroya Kinoshita
Journal:  Support Care Cancer       Date:  2015-03-17       Impact factor: 3.603

3.  Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter.

Authors:  Bhavya Voleti; David J Hammond; Avinash Thirumalai; Alok Agrawal
Journal:  Mol Immunol       Date:  2012-06-29       Impact factor: 4.407

4.  Arsenic exposure, inflammation, and renal function in Bangladeshi adults: effect modification by plasma glutathione redox potential.

Authors:  Brandilyn A Peters; Xinhua Liu; Megan N Hall; Vesna Ilievski; Vesna Slavkovich; Abu B Siddique; Shafiul Alam; Tariqul Islam; Joseph H Graziano; Mary V Gamble
Journal:  Free Radic Biol Med       Date:  2015-04-24       Impact factor: 7.376

Review 5.  C-reactive protein as a predictor of disease in smokers and former smokers: a review.

Authors:  S Tonstad; J L Cowan
Journal:  Int J Clin Pract       Date:  2009-08-29       Impact factor: 2.503

6.  Ski regulates muscle terminal differentiation by transcriptional activation of Myog in a complex with Six1 and Eya3.

Authors:  Hong Zhang; Ed Stavnezer
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

7.  Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans.

Authors:  Robert A Figler; Guoquan Wang; Susseela Srinivasan; Dae Young Jung; Zhiyou Zhang; James S Pankow; Katya Ravid; Bertil Fredholm; Catherine C Hedrick; Stephen S Rich; Jason K Kim; Kathryn F LaNoue; Joel Linden
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

8.  Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations.

Authors:  Mutsa T Madondo; Sandra Tuyaerts; Brit B Turnbull; Anke Vanderstraeten; Holbrook Kohrt; Balasubramanian Narasimhan; Frederic Amant; Michael Quinn; Magdalena Plebanski
Journal:  J Transl Med       Date:  2014-06-23       Impact factor: 5.531

9.  Individual variation in levels of haptoglobin-related protein in children from Gabon.

Authors:  Heather J Imrie; Freya J I Fowkes; Florence Migot-Nabias; Adrian J F Luty; Philippe Deloron; Stephen L Hajduk; Karen P Day
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

10.  Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer.

Authors:  S Mitsunaga; M Ikeda; S Shimizu; I Ohno; J Furuse; M Inagaki; S Higashi; H Kato; K Terao; A Ochiai
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.